期刊文献+

Effects of 95%ethanol extract of Aquilaria sinensis leaves on hyperglycemia in diabetic db/db mice 被引量:8

白木香叶95%乙醇提取物在db/db糖尿病小鼠上的降糖作用(英文)
原文传递
导出
摘要 The leaves of Aquilaria sinensis(Lour.) Gilg have been used in folk medicine for the treatment of diabetes in Guangdong Province,China.In this study,effects of ethanol extract of Aquilaria sinensis leaves on hyperglycemia were investigated in diabetic db/db mice.After 4 weeks of administration,the 95%ethanol(EtOH) extract of Aquilaria sinensis leaves (AE),especially at high dose level(600 mg/kg),activated AMP-activated protein kinase(AMPK),resulting in reduced fasting blood glucose and glycosylated hemoglobin levels in db/db mice.In addition,the oral glucose tolerance test(OGTT test) showed that AE could remarkably improve insulin resistance.Compared to Thiazolinediones(TZDs),no weight gain was observed after AE administration,which is a severe side effect of TZDs.The data suggested that AE could act as an activator of AMPK,and might be used as an alternative to TZDs in the management of obesity-related diabetes. 白木香叶为中国广东省治疗糖尿病的民间药物,关于其降糖作用和机制未见报道。本研究采用白木香叶95%乙醇提取物(AE),灌胃给药于db/db2型糖尿病小鼠,4周之后发现AE高剂量组(600 mg/kg)具有降低db/db小鼠空腹血糖和糖化血红蛋白水平,改善糖耐量的作用。作用机制研究表明,AE可能是通过激活腺苷酸活化蛋白激酶(AMPK),起到了改善胰岛素抵抗,降低血糖的作用,并且AE未表现出引起动物体重增加的副作用,可能成为噻唑烷二酮之外的治疗肥胖相关糖尿病药物的新选择。
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS 2011年第6期609-614,共6页 中国药学(英文版)
基金 New-Century Talent Program,Ministry of Educating of China(Grant No.985-2-102-113) National Key Technology R&D Program"New Drug Innovation"of China(Grant No.2009ZX09311-004,2012ZX09301-002-002-002)
关键词 Aquilaria sinensis Diabetes db/db mice Fasting glucose level HBA1C OGTT AMPK 白木香 糖尿病 db/db小鼠 空腹血糖 糖化血红蛋白 口服糖耐量 腺苷酸活化蛋白激酶
  • 相关文献

参考文献17

  • 1Blackburn, G.L. Am. J. Clin. Nutr. 2010, 91, S251-S253.
  • 2Mayerson, A.B.; Hundal, R.S.; Dufour, S.; Lebon,V.; Befroy, D.; Cline, G.W.; Enocksson, S.; Inzucchi, S.E.; Shulman, G.I.; Petersen, K.F. Diabetes. 2002, 51,797-802.
  • 3Fryer, L.G.D.; Parbu-Patel, A.; Carling, D. J. Biol. Chem. 2002, 277, 25226 25232.
  • 4Chitturi, S.; George, J. Semin Liver Dis. 2002, 22, 169- 184.
  • 5Rendell, M.S.; Kirchain, W.R. Ann. Pharmacother. 2000, 34, 878-895.
  • 6Yang, J.S.; Y.; Chen, Y.W. Acta Pharm. Sin. 1986, 7, 516-520.
  • 7Yang, J.S.; Wang, Y.L.; Su, Y.L. Acta Pharm. Sin. 1989, 24, 678-683.
  • 8Zhou, M.; Wang, H. J. Ethnopharmacol. 2008, 117, 345- 350.
  • 9Rao, Y.K.; Lee, M.J.; Chen, K.; Lee, Y.C.; Wu, W.S.; Tzeng, Y.M. Evid-Based Compl. Alt. Med. 2009, doi: 10.1093/ecam/nep204.
  • 10Shibano, M.; Tsukamoto, D.; Kusano, G. Heterocycles. 2002, 57, 1539-1553.

同被引文献104

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部